Scleritis: Clinical Trials

1 trial for Scleritis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Terminated 1

Follow Scleritis: new trials by email Literature Review of Scleritis trials Research Report on Scleritis

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study Evaluating PSI-697 in Patients With Scleritis
PSI-697 - Scleritis
Phase 1TerminatedWyeth is now a wholly owned subsidiary of Pfizer122006-09-012009-09-09

Broader conditions

Eye Diseases (1)  ·  Scleral Diseases (1)

Interventions

2-(4-chlorobenzyl)-3-hydroxy-7,8,9,10-tetrahydrobenzo(H)quinoline-4-carboxylic acid (1)

Sponsors

Wyeth is now a wholly owned subsidiary of Pfizer (1)